Stereotaxis
 | This article may have been created or edited in return for undisclosed payments, a violation of Justapedia's terms of use. It may require cleanup to comply with Justapedia's content policies, particularly neutral point of view. (July 2018) |
| Type | Public |
|---|---|
| AMEX: STXS | |
| Industry | Medical Appliances & Equipment |
Key people | David L. Fischel, CEO |
| Products | NIOBE® ES Magnetic Navigation System and Genesis RMN System |
| Website | www |
Stereotaxis Inc. is an American publicly traded corporation based in St. Louis, MO that makes robotic products to improve the clinical outcomes of electrophysiology studies.
With first iterations of the RMN system originally designed for applications within the brain, its current usage is guiding magnetic catheters during electrophysiology studies and catheter ablation procedures to treat arrhythmias within in the heart.[1] The technology has been approved by regulatory agencies in the United States, European Union and other countries. Systems operate within cardiac catheter labs in hospitals and have been utilized in over 100,000 procedures worldwide as of 2017.[2] In January 2022, Stereotaxis announced that the Fuwai Central China Cardiovascular Hospital has become the first in central China to establish a robotic electrophysiology program with the company's robotic magnetic navigation technology.[3]
References
- ^ "AccessGUDID - DEVICE: Niobe MNS Philips (M58800100610010)". accessgudid.nlm.nih.gov. Retrieved 2017-11-16.
- ^ "Stereotaxis' (STXS) CEO David Fischel on Q1 2017 Results - Earnings Call Transcript". www.msn.com. Retrieved 2017-11-16.
- ^ "Fuwai Central China Cardiovascular Hospital Adopts Stereotaxis Robotic Magnetic Navigation Technology". Surgical Robotics Technology. 2022-01-28. Retrieved 2022-01-31.